SEC Filing Summary: AspenBio Pharma, Inc.
Business Context and Reporting Period
This Form 8-K was filed by AspenBio Pharma, Inc. on September 10, 2012. The registrant is incorporated in Colorado and maintains its principal executive offices in Castle Rock, CO. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Note: The request metadata referenced "Riot Platforms, Inc.", but the provided filing text explicitly identifies the registrant as AspenBio Pharma, Inc.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure notice regarding a presentation rather than a financial statement.
Material Changes
No material changes to financial performance or operations are reported in the text of this filing. The document solely announces the furnishing of a PowerPoint presentation.
Guidance, Outlook, and Management Commentary
- Regulation FD Disclosure: The company furnished a PowerPoint presentation (Exhibit 99.1) titled "Investor Power Point Presentation" dated September 10, 2012.
- Usage: The presentation was intended for use at the Rodman & Renshaw Annual Global Investment Conference on September 10, 2012.
- Availability: The presentation is incorporated by reference and available on the Company's website.
Key Facts for Investor Verification
- Verify the content of the "Investor Power Point Presentation" (Exhibit 99.1) on the company's website for actual financial data and strategic outlook.
- Confirm the company's current status, as the filing date (2012) is historical and the company may have undergone name changes, mergers, or delisting since then.
- Note that this 8-K contains no audited financial figures; it only references external materials.